Funding for this research was provided by:
National Natural Science Foundation of China (82170110, 81971863)
Shanghai Pujiang Program (20PJ1402400)
Shanghai Natural Science Foundation (22ZR1444700)
Science and Technology Commission of Shanghai Municipality (20DZ2261200)
hanghai Municipal Science and Technology Major Project (ZD2021CY001)
Shanghai Municipal Key Clinical Specialty (shslczdzk02201)
Received: 1 November 2022
Accepted: 8 December 2022
First Online: 28 December 2022
: The study protocol was approved by the institutional review boards of Zhongshan Hospital, Fudan University, and the trial was registered on the Chinese Clinical Trial Registry (ChiCTR2200059824). All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.